NCT05090657View on ClinicalTrials.gov

Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures

PHASE2CompletedINTERVENTIONAL
Enrollment

322

Participants

Timeline

Start Date

February 4, 2022

Primary Completion Date

August 6, 2022

Study Completion Date

August 6, 2022

Conditions
Surgical Site InfectionsNosocomial InfectionHealthcare Associated Infections
Interventions
COMBINATION_PRODUCT

methylene blue 0.01%/chlorhexidine gluconate 0.25% + light activation

After topical application photosensitive solution bilateral nasal light diffusers will be inserted into each nostril and two 2-minute non-thermal light applications of 670 nm light will be used to activate the photosensitizer to achieve an oxidative burst to destroy pathogens.

Trial Locations (1)

31404

Memorial University Medical Center, Savannah

Sponsors
All Listed Sponsors
lead

Ondine Biomedical Inc.

INDUSTRY

NCT05090657 - Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures | Biotech Hunter | Biotech Hunter